These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3167207)

  • 1. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
    Shimazaki C; Wisniewski D; Scheinberg DA; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang CY; Clarkson BD
    Blood; 1988 Oct; 72(4):1248-54. PubMed ID: 3167207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ; Tong AW; Fay JW; Lee JC
    Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
    Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
    Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads.
    Reynolds CP; Seeger RC; Vo DD; Black AT; Wells J; Ugelstad J
    Cancer Res; 1986 Nov; 46(11):5882-6. PubMed ID: 3756928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
    Elias AD; Pap SA; Bernal SD
    Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
    Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
    Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
    Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
    Tong AW; Lee JC; Fay JW; Stone MJ
    Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
    Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
    Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
    De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
    Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
    Gulati SC; Shimazaki C; Lemoli RM; Atzpodien J; Clarkson BD
    Eur J Haematol Suppl; 1989; 51():164-72. PubMed ID: 2627987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
    O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
    Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of hemopoietic precursor cells from human marrow by negative selection using monoclonal antibodies and immunomagnetic beads.
    Cottler-Fox M; Bazar LS; Deeg HJ
    Prog Clin Biol Res; 1990; 333():277-84. PubMed ID: 2308986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
    Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
    Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective immunomagnetic method for bone marrow purging in T cell malignancies.
    Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
    Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
    Myklebust AT; Pharo A; Fodstad O
    Br J Cancer; 1993 Jun; 67(6):1331-6. PubMed ID: 8390285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads.
    Stoppa AM; Hirn J; Blaise D; Delaage M; Novakovitch G; Viens P; Capiello MA; Mannoni P; Mawas C; Maraninchi D
    Bone Marrow Transplant; 1990 Nov; 6(5):301-7. PubMed ID: 2291992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.